| Dr Lawrence Kendall Conger, MD | |
|
8010 Arco Corporate Pkwy, Schwarz Biosciences, Raleigh, NC 27617-2011 | |
| (919) 633-8397 | |
| Not Available |
| Full Name | Dr Lawrence Kendall Conger |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 8010 Arco Corporate Pkwy, Raleigh, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033226253 | NPI | - | NPPES |
| 5906497 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 21686 (South Carolina) | Primary |
| Entity Name | Duke University Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376574798 PECOS PAC ID: 2567372345 Enrollment ID: O20031126000274 |
News Archive
On occasion of the World TB Day, leading experts from 12 countries will take stock of the fight against tuberculosis, during a conference at the Institute of Tropical Medicine in Antwerp.
A study led by Karolinska Institutet in Sweden reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.
In an article on the U.S. Department of Defense webpage, the American Forces Press Service reports on the first U.S. National Strategy for Biosurveillance, issued by the White House "to quickly detect a range of global health and security hazards." According to the article, "the Defense Department has a running start in implementing the new plan, a senior defense official said," and "many of the activities described in the strategy are ongoing at DOD."
UMass Amherst neuroscientist Luke Remage-Healey will receive the 2012 Frank A. Beach Award from the Society for Behavioral Endocrinology for work showing exceptional promise and significant contributions in the field of behavioral neuroendocrinology. Named after a founder of the field, the award will be presented during the society's annual meeting this week in New Orleans. Remage-Healey will also give a lecture at the society's annual meeting next year.
› Verified 9 days ago
| Entity Name | Duke University Affiliated Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316975972 PECOS PAC ID: 3779489588 Enrollment ID: O20031211000642 |
News Archive
On occasion of the World TB Day, leading experts from 12 countries will take stock of the fight against tuberculosis, during a conference at the Institute of Tropical Medicine in Antwerp.
A study led by Karolinska Institutet in Sweden reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.
In an article on the U.S. Department of Defense webpage, the American Forces Press Service reports on the first U.S. National Strategy for Biosurveillance, issued by the White House "to quickly detect a range of global health and security hazards." According to the article, "the Defense Department has a running start in implementing the new plan, a senior defense official said," and "many of the activities described in the strategy are ongoing at DOD."
UMass Amherst neuroscientist Luke Remage-Healey will receive the 2012 Frank A. Beach Award from the Society for Behavioral Endocrinology for work showing exceptional promise and significant contributions in the field of behavioral neuroendocrinology. Named after a founder of the field, the award will be presented during the society's annual meeting this week in New Orleans. Remage-Healey will also give a lecture at the society's annual meeting next year.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lawrence Kendall Conger, MD 422 Marlowe Rd, Raleigh, NC 27609-7018 Ph: (919) 633-8397 | Dr Lawrence Kendall Conger, MD 8010 Arco Corporate Pkwy, Schwarz Biosciences, Raleigh, NC 27617-2011 Ph: (919) 633-8397 |
News Archive
On occasion of the World TB Day, leading experts from 12 countries will take stock of the fight against tuberculosis, during a conference at the Institute of Tropical Medicine in Antwerp.
A study led by Karolinska Institutet in Sweden reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.
In an article on the U.S. Department of Defense webpage, the American Forces Press Service reports on the first U.S. National Strategy for Biosurveillance, issued by the White House "to quickly detect a range of global health and security hazards." According to the article, "the Defense Department has a running start in implementing the new plan, a senior defense official said," and "many of the activities described in the strategy are ongoing at DOD."
UMass Amherst neuroscientist Luke Remage-Healey will receive the 2012 Frank A. Beach Award from the Society for Behavioral Endocrinology for work showing exceptional promise and significant contributions in the field of behavioral neuroendocrinology. Named after a founder of the field, the award will be presented during the society's annual meeting this week in New Orleans. Remage-Healey will also give a lecture at the society's annual meeting next year.
› Verified 9 days ago
Hershell Cassell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3400 Wake Forest Rd, Raleigh, NC 27609 Phone: 919-620-4467 | |
Christopher Occhino, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4513 Pitt St, Raleigh, NC 27609 Phone: 716-725-9852 Fax: 716-204-4501 | |
Tina M Tamaddon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 843-237-3378 Fax: 843-237-5073 | |
Rodney L Mccaskill, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 843-237-3378 Fax: 843-237-5073 | |
Colleen C Miller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4420 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-784-3100 | |
Damian Francis Mchugh, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4420 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-784-3100 |